Mexico L-carnitine Market Size & Outlook, 2020-2028

The l-carnitine market in Mexico is expected to reach a projected revenue of US$ 7.0 million by 2028. A compound annual growth rate of 4.8% is expected of Mexico l-carnitine market from 2021 to 2028.
Revenue, 2020 (US$M)
$4.8
Forecast, 2028 (US$M)
$7.0
CAGR, 2021 - 2028
4.8%
Report Coverage
Mexico

Mexico l-carnitine market highlights

  • The Mexico l-carnitine market generated a revenue of USD 4.8 million in 2020 and is expected to reach USD 7.0 million by 2028.
  • The Mexico market is expected to grow at a CAGR of 4.8% from 2021 to 2028.
  • In terms of segment, bioprocess was the largest revenue generating process in 2020.
  • Chemical Synthesis is the most lucrative process segment registering the fastest growth during the forecast period.


L-carnitine market data book summary

Market revenue in 2020USD 4.8 million
Market revenue in 2028USD 7.0 million
Growth rate4.8% (CAGR from 2020 to 2028)
Largest segmentBioprocess
Fastest growing segmentChemical Synthesis
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationChemical Synthesis, Bioprocess
Key market players worldwideLonza Group Ltd, Neogen Corp, WuXi Biologics (Cayman) Inc, Merck KGaA, Tokyo Chemical Industry, CEVA Inc


Other key industry trends

  • In terms of revenue, Mexico accounted for 2.6% of the global l-carnitine market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In North America, U.S. l-carnitine market is projected to lead the regional market in terms of revenue in 2028.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 86.1 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

L-carnitine Market Companies

Name Profile # Employees HQ Website

Mexico l-carnitine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to l-carnitine market will help companies and investors design strategic landscapes.


Bioprocess was the largest segment with a revenue share of 77.08% in 2020. Horizon Databook has segmented the Mexico l-carnitine market based on chemical synthesis, bioprocess covering the revenue growth of each sub-segment from 2017 to 2028.


According to data published by OECD, around 73% of the Mexican population was overweight or obese. The use of pharmaceuticals and supplements is increasing in the country to prevent the health issues related to obesity including diabetes, heart diseases, and high blood pressure.

The use of L-carnitine in pharmaceuticals helps to keep a check on the weight and prevents obesity-related health issues. The growing use of pharmaceuticals and supplements in Canada is expected to promote the growth of the Lcarnitine market.

Communication campaigns organized by the government and health institutes such as Obesity Prevention Campaign organized by the World Lung Foundation (WLF)/ The Union North America (UNA) to create awareness regarding the importance of a healthy lifestyle & habits have boosted the energy drinks and dietary supplement industry.

Reasons to subscribe to Mexico l-carnitine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico l-carnitine market databook

  • Our clientele includes a mix of l-carnitine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico l-carnitine market , including forecasts for subscribers. This country databook contains high-level insights into Mexico l-carnitine market from 2017 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico l carnitine market size, by process, 2017-2028 (US$M)

Mexico L-carnitine Market Outlook Share, 2020 & 2028 (US$M)

Mexico l carnitine market size, by process, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more